MRIGlobal Supports Global Health with BARDA Medical Countermeasures Development
Under the 5-year, Indefinite Delivery/Indefinite Quantity contract with a potential value of up to $100 million, MRIGlobal will support BARDA's…
MRIGlobal Leads International Research Collaboration for Tularemia Vaccine
Collaboration includes scientists from Canada, Sweden, U.S. in $6.2 million Defense Threat Reduction Agency contract award. MRIGlobal has been awarded…
MRIGlobal Furthers Study of Zika Virus
MRIGlobal Furthers Study of Zika Virus Infection Resulting in Microcephaly Using 2016 Patton Trust Research Development MRIGlobal will further study…